Tarsus Pharmaceuticals (TARS) Cash & Current Investments (2019 - 2026)
Tarsus Pharmaceuticals (TARS) posted Cash & Current Investments of $245.1 million for Q2 2026, down 13.8% from $284.5 million a year earlier and down 14.5% from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Cash & Current Investments (2019 - 2026) Analysis & Trends
At the end of FY2025, Tarsus Pharmaceuticals' Cash & Current Investments came in at $233.63 million, up 18.9% from FY2024.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of 6.8% (FY2020 to FY2025).
- In prior years, Tarsus Pharmaceuticals' Cash & Current Investments was $196.56 million in FY2024 (-13.6%), $227.44 million in FY2023 (+4.8%), $217.03 million in FY2022 (+26.3%) and $171.82 million in FY2021 (+2.2%).
- Quarterly Cash & Current Investments has run from a low of $20.21 million in Q3 2023 to a high of $289.11 million in Q3 2025 over five years.
- On a year-over-year basis, Cash & Current Investments increased in six of the last eight quarters, with growth averaging 117.2%.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2024, with growth of 596.3%; the weakest was Q2 2023, with a decline of 70.9%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $286.54 million (Q1 2026), $233.63 million (Q4 2025) and $289.11 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Tarsus Pharmaceuticals | 3.16 Bn | 2.10 Bn | 161.80 Mn | 245.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 245.10 Mn |
| Mar 31, 2026 | 286.54 Mn |
| Dec 31, 2025 | 233.63 Mn |
| Sep 30, 2025 | 289.11 Mn |
| Jun 30, 2025 | 284.50 Mn |
| Mar 31, 2025 | 232.13 Mn |
| Dec 31, 2024 | 196.56 Mn |
| Sep 30, 2024 | 140.74 Mn |
| Jun 30, 2024 | 142.49 Mn |
| Mar 31, 2024 | 104.82 Mn |
| Dec 31, 2023 | 227.44 Mn |
| Sep 30, 2023 | 20.21 Mn |
| Jun 30, 2023 | 71.46 Mn |
| Mar 31, 2023 | 135.22 Mn |
| Dec 31, 2022 | 217.03 Mn |
| Sep 30, 2022 | 57.08 Mn |
| Jun 30, 2022 | 245.40 Mn |
| Mar 31, 2022 | 175.30 Mn |
| Dec 31, 2021 | 171.82 Mn |
| Sep 30, 2021 | 183.80 Mn |
API Access
Tarsus Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();